Loading insider details...
Beta
Latest Form 4 (Apr 16, 2026): Grant/Award of 10,000 XLO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 16, 2026 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 10,000 | n/a |
| Mar 17, 2026 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 24,519 | n/a |
| Mar 11, 2026 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 20,001 | n/a |
| Mar 18, 2025 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 25,132 | n/a |
| Mar 13, 2025 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 30,060 | n/a |
| Mar 11, 2025 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 20,002 | n/a |
| Jun 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Grant/Award | 18,068 | n/a |
| May 7, 2024 | Vigil Neuroscience, Inc. (VIGL) | Disposition to Issuer | 5,017 | $48.3K |
| Mar 19, 2024 | Anika Therapeutics, Inc. (ANIK) | Grant/Award | 75,395 | n/a |
| Mar 13, 2024 | Anika Therapeutics, Inc. (ANIK) | Exercise/Conversion | 14,420 | n/a |